CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 297,474 shares at an average $2.65 ($787,716)
- SC 13G Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award President acquired 4,239 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 8,888 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 456,524 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale
- EFFECT Other Notice of Effectiveness
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 12 of 38 · 753 filings